Explore our comprehensive portfolio that addresses the complete care continuum for many of the world’s most threatening diseases. 

Discover the stories of pioneers pushing the boundaries of what’s possible in healthcare to help improve people’s lives around the world.

Patient-centered innovation has been and always will be at the core of our company. Dive deeper into our fascinating technologies.

We pioneer breakthroughs in healthcare. For everyone. Everywhere. Learn more about our purpose, our innovation leadership, our culture, and our strategy.

  1. Home

  2. Press center
  3. Press releases
  4. Siemens Healthineers further expanding AI portfolio in the field of clinical decision-making
Press release

Siemens Healthineers further expanding AI portfolio in the field of clinical decision-making

Digital European Congress of Radiology, 15th-19th of July 2020

Published on July 16, 2020

PA Chest X-ray of a patient showing an AI-Rad Companion Chest X-ray finding of a pneumothorax in the left lung. Courtesy of University Hospital Munich, Munich Germany
PA Chest X-ray of a patient showing an AI-Rad Companion Chest X-ray finding of a pneumothorax in the left lung. Courtesy of University Hospital Munich, Munich Germany

PA Chest X-ray
PA Chest X-ray of a patient showing an AI-Rad Companion Chest X-ray finding of a pneumothorax in the left lung. Courtesy of University Hospital Munich, Munich Germany

1

AI-Rad Companion Chest X-ray is currently under development; it is not for sale in the United States and other countries.

2

Tested and validated on data from Siemens Healthineers, GE and Philips devices

3

AI-Rad Companion Organs RT and Prostate MR are 510(k) pending and are not yet commercially available in the United States.

4

AI-Rad Companion Brain MR is not commercially available in all countries, and its future availability cannot be ensured.

The statements by Siemens Healthineers’ customers described herein are based on results that were achieved in the customer's unique setting. Because there is no “typical” hospital or laboratory and many variables exist (e.g., hospital size, samples mix, case mix, level of IT and/or automation adoption) there can be no guarantee that other customers will achieve the same results.

Download this press release(pdf, 169.53 KB)

Siemens Healthineers 2020

Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) is shaping the future of Healthcare. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers enables healthcare providers worldwide through its regional companies to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving the patient experience, and digitalising healthcare. Siemens Healthineers is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostics, image-guided therapy, and in-vivo diagnostics. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers’ ability to provide high-quality, efficient care to patients. In fiscal 2020, which ended on September 30, 2020, Siemens Healthineers, which has approximately 54,000 employees worldwide, generated revenue of €14.5 billion and adjusted EBIT of €2.2 billion.